Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3

被引：2

作者：

Natsuaki, Masahiro ^{[1
]}

Morimoto, Takeshi ^{[2
]}

Shiomi, Hiroki ^{[3
]}

Yamamoto, Ko ^{[3
]}

Yamaji, Kyohei ^{[4
]}

Watanabe, Hirotoshi ^{[3
]}

Uegaito, Takashi ^{[5
]}

Matsuda, Mitsuo ^{[5
]}

Tamura, Toshihiro ^{[6
]}

Taniguchi, Ryoji ^{[7
]}

Inoko, Moriaki ^{[8
]}

Mabuchi, Hiroshi ^{[9
]}

Takeda, Teruki ^{[9
]}

Domei, Takenori ^{[4
]}

Shirotani, Manabu ^{[10
]}

Ehara, Natsuhiko ^{[11
]}

Eizawa, Hiroshi ^{[12
]}

Ishii, Katsuhisa ^{[13
]}

Tanaka, Masaru ^{[14
]}

Inada, Tsukasa ^{[14
]}

Onodera, Tomoya ^{[15
]}

Nawada, Ryuzo ^{[15
]}

Shinoda, Eiji ^{[16
]}

Yamada, Miho ^{[16
]}

Yamamoto, Takashi ^{[17
]}

Sakai, Hiroshi ^{[17
]}

Toyofuku, Mamoru ^{[18
]}

Tamura, Takashi ^{[18
]}

Takahashi, Mamoru ^{[19
]}

Tada, Tomohisa ^{[20
]}

Sakamoto, Hiroki ^{[20
]}

Tada, Takeshi ^{[21
]}

Kaneda, Kazuhisa ^{[3
]}

Miki, Shinji ^{[22
]}

Aoyama, Takeshi ^{[23
]}

Suwa, Satoru ^{[24
]}

Sato, Yukihito ^{[7
]}

Ando, Kenji ^{[4
]}

Furukawa, Yutaka ^{[11
]}

Nakagawa, Yoshihisa ^{[17
]}

Kadota, Kazushige ^{[21
]}

Kimura, Takeshi ^{[3
]}

机构：

[1] Saga Univ, Dept Cardiovasc Med, Saga, Japan

[2] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan

[4] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan

[5] Kishiwada City Hosp, Dept Cardiol, Kishiwada, Japan

[6] Tenri Hosp, Dept Cardiol, Tenri, Nara, Japan

[7] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan

[8] Kitano Hosp, Dept Cardiol, Osaka, Japan

[9] Koto Mem Hosp, Dept Cardiol, Higashiomi, Japan

[10] Kindai Univ, Dept Cardiol, Nara Hosp, Ikoma, Japan

[11] Kobe City Med Ctr, Dept Cardiovasc Med, Gen Hosp, Kobe, Hyogo, Japan

[12] Kobe City Nishi Kobe Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan

[13] Kansai Denryoku Hosp, Dept Cardiol, Osaka, Japan

[14] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan

[15] Shizuoka City Shizuoka Hosp, Dept Cardiol, Shizuoka, Japan

[16] Hamamatsu Rosai Hosp, Dept Cardiol, Hamamatsu, Shizuoka, Japan

[17] Shiga Univ Med Sci Hosp, Dept Cardiol, Otsu, Shiga, Japan

[18] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan

[19] Shimabara Hosp, Dept Cardiol, Kyoto, Japan

[20] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan

[21] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan

[22] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan

[23] Shimada Municipal Hosp, Div Cardiol, Shimada, Japan

[24] Juntendo Univ, Dept Cardiol, Shizuoka Hosp, Izunokuni, Japan

来源：

CIRCULATION JOURNAL | 2022年 / 86卷 / 05期

关键词：

  Coronary artery disease; High bleeding risk; Percutaneous coronary intervention; DUAL ANTIPLATELET THERAPY; BARE-METAL; CARDIOVASCULAR EVENTS; STENT; CLOPIDOGREL; MONOTHERAPY; TICAGRELOR; TRENDS;

D O I：

10.1253/circj.CJ-21-0526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Optimal intensity is unclear for P2Y12 receptor blocker therapy after percutaneous coronary intervention (PCI) in realMethods and Results: From the CREDO-Kyoto Registry, the current study population consisted of 25,419 patients (Cohort-2: n=12,161 and Cohort-3: n=13,258) who underwent their first PCI. P2Y12 receptor blocker therapies were reduced dose of ticlopidine (200 mg/day), and global dose of clopidogrel (75 mg/day) in 87.7% and 94.8% of patients in Cohort-2 and Cohort-3, respectively. Cumulative 3-year incidence of GUSTO moderate/severe bleeding was significantly higher in Cohort-3 than in Cohort-2 (12.1% and 9.0%, P<0.0001). After adjusting 17 demographic factors and 9 management factors potentially related to the bleeding events other than the type of P2Y12 receptor blocker, the higher bleeding risk in Cohort-3 relative to Cohort-2 remained significant (hazard ratio (HR): 1.52 95% confidence interval (CI) 1.37-1.68, P<0.0001). Cohort-3 compared with Cohort-2 was not associated with lower adjusted risk for myocardial infarction/ischemic stroke (HR: 0.96, 95% CI: 0.87-1.06, P=0.44). Conclusions: In this historical comparative study, Cohort-3 compared with Cohort-2 was associated with excess bleeding risk, which might be at least partly explained by the difference in P2Y12 receptor blockers.

引用

页码：748 / +

页数：30

共 50 条

[31] Impact of Statin Therapy on Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (from the CREDO-Kyoto Registry Cohort-2)
Natsuaki, Masahiro
Nakagawa, Yoshihisa
Morimoto, Takeshi
Ono, Koh
Shizuta, Satoshi
Furukawa, Yutaka
Kadota, Kazushige
Iwabuchi, Masashi
Kato, Yoshihiro
Suwa, Satoru
Inada, Tsukasa
Doi, Osamu
Takizawa, Akinori
Nobuyoshi, Masakiyo
Kita, Toru
Kimura, Takeshi
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (10): : 1387 - 1396
[32] Impact of Coronary Artery Bypass Surgery in Patients With Ischemic Heart Failure: 5-Year Outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2
Marui, Akira
Kimura, Takeshi
Shiomi, Hiroki
Tanaka, Shiro
Hanyu, Michiya
Komiya, Tatsuhiko
Kita, Toru
Sakata, Ryuzo
CIRCULATION, 2013, 128 (22)
[33] Comparison of Five-Year Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Ejection Fractions ≤50% Versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)
Marui, Akira
Kimura, Takeshi
Nishiwaki, Noboru
Mitsudo, Kazuaki
Komiya, Tatsuhiko
Hanyu, Michiya
Shiomi, Hiroki
Tanaka, Shiro
Sakata, Ryuzo
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (07): : 988 - 996
[34] Intensity of Statin Therapy, Achieved Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization - Perspectives From the CREDO-Kyoto Registry Cohort-2
Natsuaki, Masahiro
Furukawa, Yutaka
Morimoto, Takeshi
Nakagawa, Yoshihisa
Ono, Koh
Kaburagi, Satoshi
Inada, Tsukasa
Mitsuoka, Hirokazu
Taniguchi, Ryoji
Nakano, Akira
Kita, Tow
Sakata, Ryuzo
Kimura, Takeshi
CIRCULATION JOURNAL, 2012, 76 (06) : 1369 - 1379
[35] Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: A report from the CREDO-Kyoto PCI/CABG Registry Cohort-2
Tokushige A.
Shiomi H.
Morimoto T.
Ono K.
Furukawa Y.
Nakagawa Y.
Kadota K.
Iwabuchi M.
Shizuta S.
Tada T.
Tazaki J.
Kato Y.
Hayano M.
Abe M.
Hamasaki S.
Tei C.
Nakashima H.
Mitsudo K.
Nobuyoshi M.
Kita T.
Kimura T.
Cardiovascular Intervention and Therapeutics, 2013, 28 (1) : 45 - 55
[36] Influence of Initial Acute Myocardial Infarction Presentation on the Outcome of Surgical Procedure after Coronary Stent Implantation: A Report from the CREDO-Kyoto PCl/CABC Registry Cohort-2
Tokushige, Akihiro
Shiomi, Hiroki
Morimoto, Takeshi
Furukawa, Yutaka
Nakagawa, Yoshihisa
Kadota, Kazushige
Iwabuchi, Masashi
Shizuta, Satoshi
Abe, Mitsuru
Ehara, Natsuhiko
Inada, Tsukasa
Kaburagi, Satoshi
Hamasaki, Shuichi
Tei, Chuwa
Nakashima, Hitoshi
Ogawa, Hisao
Tatami, Ryozo
Suwa, Satoru
Takizawa, Akinori
Nohara, Ryuji
Fujiwara, Hisayoshi
Mitsudo, Kazuaki
Nobuyoshi, Masakiyo
Kita, Toru
Kimura, Takeshi
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 67S - 67S
[37] Incidence and Outcome of Surgical Procedures After Coronary Bare-Metal and Drug-Eluting Stent Implantation A Report From the CREDO-Kyoto PCI/CABG Registry Cohort-2
Tokushige, Akihiro
Shiomi, Hiroki
Morimoto, Takeshi
Furukawa, Yutaka
Nakagawa, Yoshihisa
Kadota, Kazushige
Iwabuchi, Masashi
Shizuta, Satoshi
Tada, Tomohisa
Tazaki, Junichi
Kato, Yoshihiro
Hayano, Mamoru
Abe, Mitsuru
Ehara, Natsuhiko
Inada, Tsukasa
Kaburagi, Satoshi
Hamasaki, Shuichi
Tei, Chuwa
Nakashima, Hitoshi
Ogawa, Hisao
Tatami, Ryozo
Suwa, Satoru
Takizawa, Akinori
Nohara, Ryuji
Fujiwara, Hisayoshi
Mitsudo, Kazuaki
Nobuyoshi, Masakiyo
Kita, Toru
Kimura, Takeshi
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 237 - 246
[38] Risk of bleeding among diabetic patients treated with drug-eluting stents for coronary artery disease: 5-year results from CREDO-Kyoto PCI/CABG Registry Cohort-2
Tada, Tomohisa
Furukawa, Yutaka
Kadota, Kazushige
Kimura, Takeshi
Nakagawa, Yoshihisa
Ono, Koh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B93 - B94
[39] Long-term clinical outcomes and duration of dual antiplatelet therapy after drug-eluting stent implantation: landmark analyses from CREDO-KYOTO Cohort-2 registry
Tada, T.
Natsuaki, M. N.
Morimoto, T.
Furukawa, Y.
Nakagawa, Y.
Kadota, K.
Mitsudo, K.
Nobuyoshi, M.
Kita, T.
Kimura, T.
EUROPEAN HEART JOURNAL, 2011, 32 : 509 - 509
[40] Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3)
Matsumura-Nakano, Yukiko
Shiomi, Hiroki
Morimoto, Takeshi
Yamaji, Kyohei
Ehara, Natsuhiko
Sakamoto, Hiroki
Takeji, Yasuaki
Yoshikawa, Yusuke
Yamamoto, Ko
Imada, Kazuaki
Tada, Takeshi
Taniguchi, Ryoji
Nishikawa, Ryusuke
Tada, Tomohisa
Uegaito, Takashi
Ogawa, Tatsuya
Yamada, Miho
Takeda, Teruki
Eizawa, Hiroshi
Tamura, Nobushige
Tambara, Keiichi
Suwa, Satoru
Shirotani, Manabu
Tamura, Toshihiro
Inoko, Moriaki
Nishizawa, Junichiro
Natsuaki, Masahiro
Sakai, Hiroshi
Yamamoto, Takashi
Kanemitsu, Naoki
Ohno, Nobuhisa
Ishii, Katsuhisa
Marui, Akira
Tsuneyoshi, Hiroshi
Terai, Yasuhiko
Nakayama, Shogo
Yamazaki, Kazuhiro
Takahashi, Mamoru
Tamura, Takashi
Esaki, Jiro
Miki, Shinji
Onodera, Tomoya
Mabuchi, Hiroshi
Furukawa, Yutaka
Tanaka, Masaru
Komiya, Tatsuhiko
Soga, Yoshiharu
Hanyu, Michiya
Ando, Kenji
Kadota, Kazushige
AMERICAN JOURNAL OF CARDIOLOGY, 2021, 145 : 25 - 36

← 1 2 3 4 5 →